1. Home
  2. NEXT vs SUPN Comparison

NEXT vs SUPN Comparison

Compare NEXT & SUPN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NEXT
  • SUPN
  • Stock Information
  • Founded
  • NEXT 2010
  • SUPN 2005
  • Country
  • NEXT United States
  • SUPN United States
  • Employees
  • NEXT N/A
  • SUPN N/A
  • Industry
  • NEXT Oil & Gas Production
  • SUPN Biotechnology: Pharmaceutical Preparations
  • Sector
  • NEXT Energy
  • SUPN Health Care
  • Exchange
  • NEXT Nasdaq
  • SUPN Nasdaq
  • Market Cap
  • NEXT 1.9B
  • SUPN 2.0B
  • IPO Year
  • NEXT N/A
  • SUPN 2012
  • Fundamental
  • Price
  • NEXT $6.59
  • SUPN $36.45
  • Analyst Decision
  • NEXT Hold
  • SUPN Hold
  • Analyst Count
  • NEXT 1
  • SUPN 1
  • Target Price
  • NEXT $9.00
  • SUPN $36.00
  • AVG Volume (30 Days)
  • NEXT 1.7M
  • SUPN 285.1K
  • Earning Date
  • NEXT 11-07-2024
  • SUPN 11-04-2024
  • Dividend Yield
  • NEXT N/A
  • SUPN N/A
  • EPS Growth
  • NEXT N/A
  • SUPN 130.79
  • EPS
  • NEXT N/A
  • SUPN 1.07
  • Revenue
  • NEXT N/A
  • SUPN $651,972,000.00
  • Revenue This Year
  • NEXT N/A
  • SUPN $7.82
  • Revenue Next Year
  • NEXT N/A
  • SUPN N/A
  • P/E Ratio
  • NEXT N/A
  • SUPN $34.11
  • Revenue Growth
  • NEXT N/A
  • SUPN 6.79
  • 52 Week Low
  • NEXT $4.26
  • SUPN $25.53
  • 52 Week High
  • NEXT $8.52
  • SUPN $39.37
  • Technical
  • Relative Strength Index (RSI)
  • NEXT 44.38
  • SUPN 48.87
  • Support Level
  • NEXT $6.53
  • SUPN $35.68
  • Resistance Level
  • NEXT $7.03
  • SUPN $37.35
  • Average True Range (ATR)
  • NEXT 0.25
  • SUPN 1.01
  • MACD
  • NEXT -0.09
  • SUPN -0.18
  • Stochastic Oscillator
  • NEXT 12.82
  • SUPN 21.65

About NEXT NextDecade Corporation

NextDecade Corp is a energy company predominantly engaged in construction and development activities related to the liquefaction of natural gas and sale of LNG and the capture and storage of CO2 emissions. The company provides a number of services depending on the individual needs of the customer. These include the supply and trade of LNG volumes, the creation of new natural gas infrastructure including pipeline and natural gas liquefaction facilities, treatment and processing of natural gas into LNG, as well as technical engineering and design services related to the development and execution of natural gas infrastructure, transporting, shipping and storage of LNG.

About SUPN Supernus Pharmaceuticals Inc.

Supernus Pharmaceuticals Inc is a specialty pharmaceutical company. The company is engaged in developing and commercializing products for the treatment of central nervous system diseases, including neurological and psychiatric disorders. The Company's diverse neuroscience portfolio includes approved treatments for epilepsy, migraine, attention-deficit hyperactivity disorder (ADHD), hypomobility in Parkinson's Disease (PD), cervical dystonia, chronic sialorrhea, dyskinesia in PD patients receiving levodopa-based therapy, and drug-induced extrapyramidal reactions in adult patients. The company products include Trokendi XR, Oxtellar XR, Qelbree, APOKYN, XADAGO, MYOBLOC, GOCOVRI, and Osmolex ER.

Share on Social Networks: